Carmat

CARMAT is a medical technology company that provides biocompatible, self-regulating total artificial hearts, including left and right ventricles designed to be as close as possible to the human heart. It is intended for patients with chronic end-stage heart failure who have reached Class IV of the New York Heart Association classification; or acute end-stage heart failure following a massive myocardial infarction.CARMAT aims to offer reliable new therapies and innovative treatment options for heart failure patients who are not eligible for transplantation and have exhausted all drug-related possibilities.